Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists

The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZIERHUT MATTHEW L, CIRINCIONE BRENDA B
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZIERHUT MATTHEW L
CIRINCIONE BRENDA B
description The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN103906528A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN103906528A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN103906528A3</originalsourceid><addsrcrecordid>eNqNzL0KwjAUxfEsDqK-w_UBCq1F0VGKH4OKg5tDSZuTNlCT0ntFH98IPoDTGf4_zljdz5A2GCYbBpIBWpxvyDhdQcD0ctIS3gJvYGhAB8342sezizR4pmDpcLomWaw1eok3ugnesfBUjazuGLPfTtR8v7sVxwR9KMG9ruEhZXHJ0nyTrpaL9Tb_x3wAZUA7Uw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><source>esp@cenet</source><creator>ZIERHUT MATTHEW L ; CIRINCIONE BRENDA B</creator><creatorcontrib>ZIERHUT MATTHEW L ; CIRINCIONE BRENDA B</creatorcontrib><description>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140702&amp;DB=EPODOC&amp;CC=CN&amp;NR=103906528A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140702&amp;DB=EPODOC&amp;CC=CN&amp;NR=103906528A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZIERHUT MATTHEW L</creatorcontrib><creatorcontrib>CIRINCIONE BRENDA B</creatorcontrib><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><description>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzL0KwjAUxfEsDqK-w_UBCq1F0VGKH4OKg5tDSZuTNlCT0ntFH98IPoDTGf4_zljdz5A2GCYbBpIBWpxvyDhdQcD0ctIS3gJvYGhAB8342sezizR4pmDpcLomWaw1eok3ugnesfBUjazuGLPfTtR8v7sVxwR9KMG9ruEhZXHJ0nyTrpaL9Tb_x3wAZUA7Uw</recordid><startdate>20140702</startdate><enddate>20140702</enddate><creator>ZIERHUT MATTHEW L</creator><creator>CIRINCIONE BRENDA B</creator><scope>EVB</scope></search><sort><creationdate>20140702</creationdate><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><author>ZIERHUT MATTHEW L ; CIRINCIONE BRENDA B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN103906528A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ZIERHUT MATTHEW L</creatorcontrib><creatorcontrib>CIRINCIONE BRENDA B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZIERHUT MATTHEW L</au><au>CIRINCIONE BRENDA B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists</title><date>2014-07-02</date><risdate>2014</risdate><abstract>The disclosure provides methods for treating diabetes, treating overweight, treating obesity, reducing body weight, treating cardiovascular diseases, treating fatty liver diseases, treating gastrointestinal diseases, and treating neurodegenerative diseases through the once monthly administration of pharmaceutical formulations containing a non-aqueous carrier and GLP-1 receptor agonists that provides therapeutically effective plasma concentration levels of the GLP-1 receptor agonists over the course of a month.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN103906528A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Methods for treating diabetes with extended release formulations of GLP-1 receptor agonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A09%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZIERHUT%20MATTHEW%20L&rft.date=2014-07-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN103906528A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true